Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.7 USD | +3.10% | +3.25% | +7.75% |
01:27pm | Pfizer vs Moderna battle over COVID vaccine patents begins in UK | RE |
Apr. 22 | Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.75% | 40B | |
+1.96% | 42.11B | |
+48.83% | 40.08B | |
-10.82% | 26.87B | |
+7.69% | 24.58B | |
-23.49% | 18.44B | |
+2.36% | 11.94B | |
+31.03% | 11.66B | |
+7.39% | 11.01B | |
-16.93% | 9.87B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Chardan Lowers Price Target on Moderna to $186 From $188, Maintains Buy Rating